What to Expect During Routine Monitoring Visits in Clinical Trials
The primary purpose of RMVs is to:
Click to read the full article.
The primary purpose of RMVs is to:
Click to read the full article.
Determining how often and how much data to verify depends on multiple factors:
Click to read the full article.
Well-planned RMV schedules ensure:
Click to read the full article.
SDV errors refer to mismatches or discrepancies between the data entered into the Case Report Forms (CRFs) and the source documentation maintained by the trial site. These may arise due to incorrect transcription, missing data, untimely updates, or lack of understanding of the protocol requirements.
Click to read the full article.
SDV refers to the process of checking that the data recorded in Case Report Forms (CRFs) or Electronic Data Capture (EDC) systems accurately reflect the original source documents. CRAs (Clinical Research Associates) perform SDV to confirm that trial data is:
Click to read the full article.
Site staff should come away from SDV training with the ability to:
Click to read the full article.
EMRs are digital platforms that store patient information, including clinical visits, medications, diagnoses, test results, and imaging. In clinical trials, EMRs often serve as the primary source of truth for verifying data entered in the Case Report Form (CRF). Since CRAs don’t interact with the patients directly, the EMR is their key validation tool.
Click to read the full article.
EMRs serve as the official source for clinical information such as diagnoses, lab values, and treatment history. For SDV purposes, CRAs must access specific, protocol-relevant data while ensuring compliance with Good Clinical Practice (GCP) and privacy regulations like USFDA and EMA requirements.
Click to read the full article.
EMRs serve as the official source for clinical information such as diagnoses, lab values, and treatment history. For SDV purposes, CRAs must access specific, protocol-relevant data while ensuring compliance with Good Clinical Practice (GCP) and privacy regulations like USFDA and EMA requirements.
Click to read the full article.
Patient confidentiality is a fundamental ethical and legal requirement in clinical trials. During SDV, if privacy safeguards are not followed, there can be risks of data breaches, regulatory non-compliance, and loss of trial credibility. Authorities like the USFDA and EMA mandate that personal health information (PHI) be accessed and handled securely and only by authorized personnel.
Click to read the full article.
